Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARDOM1: MR308 (Seglentis) for Acute Pain After Third Molar Extraction
NCT02982161Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Dec 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 3, randomised, double-blind trial of tramadol in acute pain (5 arms), sponsored by Mundipharma. Primary endpoint: Sum of Pain Intensity Differences. Started Dec 2016; status: completed.
02
Drugs
tramadol
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02982161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02982161.